NEVERMIND COFFEE HOUR IS A SERIES OF WEBINARS ORGANIZED BY THE #NEVERMIND CONSORTIUM TO DISSEMINATE KNOWLEDGE ABOUT NANOMEDICINE, NEUROSCIENCE AND NEURODEGENERATION TO RESEARCHERS, STUDENTS AND EVERYONE WHO IS INTERESTED IN LEARNING MORE ABOUT THESE TOPICS.
The Dissemination plan of the project included in presence symposia.
Unfortunately, due to the pandemic, it was non recommended to organize it in this period of the year. Nonetheless, we all agreed that discussion and debate is essential for scientific research to be innovative and dynamic. For these reasons, we have chosen to shift to virtual short webinars.
EVERY WEBINAR IS FOCUSSED ON A DIFFERENT TOPIC AND ORGANIZED BY ONE OF THE PARTNERS OF THE NEVERMIND CONSORTIUM
Here a brief summary of the past webinars.
1. FIRST NEVERMIND COFFEE HOUR, 2nd December 2021:
Silvia Picciolini from LABION (Fondazione Don Carlo Gnocchi) and Augustin Enciso Martinez from the University of Twente have discussed about BIOPHOTONICS IN NANOMEDICINE.
After a brief introduction by the Coordinator of the Nevermind project, Dr. Bedoni, the two invited speakers have described recent achievements in the field of nanomedicine, focussing on the appication of Raman spectroscopy and Surface Plasmon Resonance imaging, in the search for biomarkers fotr neurological diseases and cancer. Both reported interesting results in the application of biophotonics for the characterization of extracellular vesicles from human biofluids. Dr. Picciolini has also described the impact of biophotonics also in the study of nanodrugs, refererring about the work of Labion within the Nevermind project.
2. SECOND NEVERMIND COFFEE HOUR, 17th December 2021:
Francesca La Rosa from the Laboratory of Molecular Medicine and Biotechnologies (Fondazione Don Carlo Gnocchi) and Carmen Venegas Maldonado from the University of Luxembourg have discussed about NEURODEGENERATION AND INFLAMMATION.
After a brief introduction by Dr. Saresella of the Nevermind Consortium, the two invited speakers have described recent achievements in the field of neuroinflammation. Both researchers have deepened the role of the inflammosome in neurodegeneration, in particular in Alzheimer’s disease. Dr. La Rosa has also described the importance of studying teh impact of nanodrugs on neuroinflammation, describing the recent achievemnts obtained in the framework of the Nevermind project.
3. THIRD NEVERMIND COFFEE HOUR, 27th January 2022:
Roberto Furlan and Luca Muzio from San Raffaele Scientific Institute have discussed about MANAGING BRAIN INFLAMMATION IN EXPERIMENTAL MODELS.
Moderated by Dr. Andrea Menegon, the webinar started with the talk of Dr. Furlan about extracellular vesicles in the central nervous system. The first part of the presentation focused on the study of the role of myeloid extracellular vesicles present in the cerebrospinal fluid in Multiple Sclerosis diagnosis and prognosis, presenting encouraging results on the potentialities of these vesicles as biomarkers of the disease. The second part of Dr. Furlan’s talk was about the influence of different protocols of isolation and storage of samples on the properties of extracellular vesicles, pointing out the importance of defining standardized procedures to be followed in order not to change the fate and destiny of extracellular vesicles during their study.
Dr. Muzio gave an interesting talk about new tools to regulate neuroinflammation explaining that diseases driven by ongoing inflammation could be treated by activating or enhancing resolution pathways, rather than simply stopping inflammation in its tracks. He introduced the hybrid recto proteins that are able to downregulate many pro-inflammatory factors having beneficial effects on a broad spectrum of immune and inflammatory diseases.
